You just read:

BioLineRx Announces Regulatory Submissions for Phase 2a Trial of BL-8040 in Combination with KEYTRUDA® (pembrolizumab) for Treatment of Pancreatic Cancer

News provided by

BioLineRx Ltd.

28 Jun, 2016, 07:00 ET